Acute suppression of apo B secretion by insulin occurs independently of MTP

Biochemical and Biophysical Research Communications

Volumn 406, Issue 2, 2011, Pages 252-256

  Sparks, Janet D ^a   Chamberlain, Jeffrey M ^a   O'Dell, Colleen ^a   Khatun, Irani ^b   Hussain, M Mahmood ^b   Sparks, Charles E ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Forkhead transcription factor; FoxO1; Insulin; Lipoprotein secretion; MTP

Indexed keywords

APOLIPOPROTEIN B; INSULIN; MESSENGER RNA; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN;

ANIMAL CELL; ARTICLE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GLUCONEOGENESIS; IN VIVO STUDY; INCUBATION TIME; LIPID TRANSPORT; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; APOLIPOPROTEINS B; CARRIER PROTEINS; CELLS, CULTURED; HUMANS; INSULIN; LIPOPROTEINS, VLDL; LIVER; MALE; MICE; MICE, MUTANT STRAINS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANSFECTION;

MUS; RATTUS;

EID: 79952450257     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.02.028     Document Type: Article

References (35)

1. Sparks J.D., Sparks C.E. Overindulgence and metabolic syndrome: is FoxO1 a missing link?. J. Clin. Invest. 2008, 118:2012-2015.
2. Elovson J., Chatterton J.E., Bell G.T., Schumaker V.N., Reuben M.A., Puppione D.L., Reeve J.R., Young N.L. Plasma very low density lipoproteins contain a single molecule of apolipoprotein B. J. Lipid Res. 1988, 29:1461-1473.
3. Hussain M.M., Bakillah A. New approaches to target microsomal triglyceride transfer protein. Curr. Opin. Lipidol. 2008, 19:572-578.
4. Hussain M.M., Shi J., Dreizen P. Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly. J. Lipid Res. 2003, 44:22-32.
5. Sparks J.D., Dong H.H. FoxO1 and hepatic lipid metabolism. Curr. Opin. Lipidol. 2009, 20:217-226.
6. Sparks J.D., Sparks C.E. Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes. J. Biol. Chem. 1990, 265:8854-8862.
7. Sparks J.D., Phung T.L., Bolognino M., Sparks C.E. Insulin-mediated inhibition of apolipoprotein B secretion requires an intracellular trafficking event and phosphatidylinositol 3-kinase activation: studies with brefeldin A and wortmannin in primary cultures of rat hepatocytes. Biochem. J. 1996, 313(Pt. 2):567-574.
8. Fisher E.A., Pan M., Chen X., Wu X., Wang H., Jamil H., Sparks J.D., Williams K.J. The triple threat to nascent apolipoprotein B. Evidence for multiple, distinct degradative pathways. J. Biol. Chem. 2001, 276:27855-27863.
9. Phung T.L., Roncone A., Jensen K.L., Sparks C.E., Sparks J.D. Phosphoinositide 3-kinase activity is necessary for insulin-dependent inhibition of apolipoprotein B secretion by rat hepatocytes and localizes to the endoplasmic reticulum. J. Biol. Chem. 1997, 272:30693-30702.
10. Kamagate A., Qu S., Perdomo G., Su D., Kim D.H., Slusher S., Meseck M., Dong H.H. FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice. J. Clin. Invest. 2008, 118:2347-2364.
11. Imae M., Fu Z., Yoshida A., Noguchi T., Kato H. Nutritional and hormonal factors control the gene expression of FoxOs, the mammalian homologues of DAF-16. J. Mol. Endocrinol. 2003, 30:253-262.
12. Qu S., Altomonte J., Perdomo G., He J., Fan Y., Kamagate A., Meseck M., Dong H.H. Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism. Endocrinology 2006, 147:5641-5652.
13. Athar H., Iqbal J., Jiang X.C., Hussain M.M. A simple, rapid, and sensitive fluorescence assay for microsomal triglyceride transfer protein. J. Lipid Res. 2004, 45:764-772.
14. Pan X., Hussain M.M. Diurnal regulation of microsomal triglyceride transfer protein and plasma lipid levels. J. Biol. Chem. 2007, 282:24707-24719.
15. Rava P., Athar H., Johnson C., Hussain M.M. Transfer of cholesteryl esters and phospholipids as well as net deposition by microsomal triglyceride transfer protein. J. Lipid Res. 2005, 46:1779-1785.
16. Sparks J.D., Corsetti J.P., Sparks C.E. Liver regrowth and apolipoprotein B secretion by rat hepatocytes following partial hepatectomy. Metabolism 1994, 43:681-690.
17. Sparks J.D., Bolognino M., Trax P.A., Sparks C.E. The production and utility of monoclonal antibodies to rat apolipoprotein B lipoproteins. Atherosclerosis 1986, 61:205-211.
18. Chirieac D.V., Chirieac L.R., Corsetti J.P., Cianci J., Sparks C.E., Sparks J.D. Glucose-stimulated insulin secretion suppresses hepatic triglyceride-rich lipoprotein and apoB production. Am. J. Physiol. Endocrinol. Metab. 2000, 279:E1003-E1011.
19. Chirieac D.V., Davidson N.O., Sparks C.E., Sparks J.D. PI3-kinase activity modulates apo B available for hepatic VLDL production in apobec-1-/- mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 291:G382-G388.
20. Au W.S., Kung H.F., Lin M.C. Regulation of microsomal triglyceride transfer protein gene by insulin in HepG2 cells: roles of MAPKerk and MAPKp38. Diabetes 2003, 52:1073-1080.
21. Lin M.C., Gordon D., Wetterau J.R. Microsomal triglyceride transfer protein (MTP) regulation in HepG2 cells: insulin negatively regulates MTP gene expression. J. Lipid Res. 1995, 36:1073-1081.
22. Allister E.M., Borradaile N.M., Edwards J.Y., Huff M.W. Inhibition of microsomal triglyceride transfer protein expression and apolipoprotein B100 secretion by the citrus flavonoid naringenin and by insulin involves activation of the mitogen-activated protein kinase pathway in hepatocytes. Diabetes 2005, 54:1676-1683.
23. Dashti N., Williams D.L., Alaupovic P. Effects of oleate and insulin on the production rates and cellular mRNA concentrations of apolipoproteins in HepG2 cells. J. Lipid Res. 1989, 30:1365-1373.
24. Elshourbagy N.A., Boguski M.S., Liao W.S., Jefferson L.S., Gordon J.I., Taylor J.M. Expression of rat apolipoprotein A-IV and A-I genes: mRNA induction during development and in response to glucocorticoids and insulin. Proc. Natl. Acad. Sci. USA 1985, 82:8242-8246.
25. Ogbonna G., Theriault A., Adeli K. Hormonal regulation of human apolipoprotein E gene expression in HepG2 cells. Int. J. Biochem. 1993, 25:635-640.
26. Pullinger C.R., North J.D., Teng B.B., Rifici V.A., Ronhild de Brito A.E., Scott J. The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life. J. Lipid Res. 1989, 30:1065-1077.
27. Puigserver P., Rhee J., Donovan J., Walkey C.J., Yoon J.C., Oriente F., Kitamura Y., Altomonte J., Dong H., Accili D., Spiegelman B.M. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 2003, 423:550-555.
28. Dentin R., Liu Y., Koo S.H., Hedrick S., Vargas T., Heredia J., Yates J., Montminy M. Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. Nature 2007, 449:366-369.
29. Herzig S., Long F., Jhala U.S., Hedrick S., Quinn R., Bauer A., Rudolph D., Schutz G., Yoon C., Puigserver P., Spiegelman B., Montminy M. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 2001, 413:179-183.
30. Chandler C.E., Wilder D.E., Pettini J.L., Savoy Y.E., Petras S.F., Chang G., Vincent J., Harwood H.J. CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans. J. Lipid Res. 2003, 44:1887-1901.
31. Shiomi M., Ito T. MTP inhibitor decreases plasma cholesterol levels in LDL receptor-deficient WHHL rabbits by lowering the VLDL secretion. Eur. J. Pharmacol. 2001, 431:127-131.
32. Wetterau J.R., Gregg R.E., Harrity T.W., Arbeeny C., Cap M., Connolly F., Chu C.H., George R.J., Gordon D.A., Jamil H., Jolibois K.G., Kunselman L.K., Lan S.J., Maccagnan T.J., Ricci B., Yan M., Young D., Chen Y., Fryszman O.M., Logan J.V., Musial C.L., Poss M.A., Robl J.A., Simpkins L.M., Slusarchyk W.A., Sulsky R., Taunk P., Magnin D.R., Tino J.A., Lawrence R.M., Dickson J.K., Biller S.A. An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits. Science 1998, 282:751-754.
33. Bakillah A., Nayak N., Saxena U., Medford R.M., Hussain M.M. Decreased secretion of ApoB follows inhibition of ApoB-MTP binding by a novel antagonist. Biochemistry 2000, 39:4892-4899.
34. Tietge U.J., Bakillah A., Maugeais C., Tsukamoto K., Hussain M., Rader D.J. Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B. J. Lipid Res. 1999, 40:2134-2139.
35. Liao W., Kobayashi K., Chan L. Adenovirus-mediated overexpression of microsomal triglyceride transfer protein (MTP): mechanistic studies on the role of MTP in apolipoprotein B-100 biogenesis. Biochemistry 1999, 38:7532-7544.